semaglutide weight regain after stopping Two Years GLP-1s, Most Patients Sustain at Least Some Loss Surgeon's Warning About Weight Gain

These injections provide a medically supported path to sustainable weight loss, especially for those who have struggled with other methods

Unfortunately, recent studies have found that the use of certain GLP-1 receptor agonist medications such as Ozempic, Wegovy, Rybelsus and other GLP-1 medications may be associated with an increased risk of developing non-arteritic anterior ischemic optic neuropathy or NAION

What starts as a discussion about how these medications work in the brain quickly turns into something much deeper

This flexibility is essential for a lasting GLP-1 wellness routine

Adults in Springfield, Oregon with a BMI of 30 or greater, or 27 or greater combined with a weight-related health condition, may be excellent candidates for Klinic's weight loss medications